214 related articles for article (PubMed ID: 21423422)
1. Strain-specific battery of tests for domains of mania: effects of valproate, lithium and imipramine.
Flaisher-Grinberg S; Einat H
Front Psychiatry; 2010; 1():10. PubMed ID: 21423422
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of high sweet solution preference by mood stabilizers: a possible mouse model for the increased reward-seeking domain of mania.
Flaisher-Grinberg S; Overgaard S; Einat H
J Neurosci Methods; 2009 Feb; 177(1):44-50. PubMed ID: 18930764
[TBL] [Abstract][Full Text] [Related]
3. Modeling mania: Further validation for Black Swiss mice as model animals.
Hannah-Poquette C; Anderson GW; Flaisher-Grinberg S; Wang J; Meinerding TM; Einat H
Behav Brain Res; 2011 Sep; 223(1):222-6. PubMed ID: 21570428
[TBL] [Abstract][Full Text] [Related]
4. Partial effects of the AMPAkine CX717 in a strain specific battery of tests for manic-like behavior in black Swiss mice.
Kara NZ; Flaisher-Grinberg S; Einat H
Pharmacol Rep; 2015 Oct; 67(5):928-33. PubMed ID: 26398387
[TBL] [Abstract][Full Text] [Related]
5. A possible utilization of the mice forced swim test for modeling manic-like increase in vigor and goal-directed behavior.
Flaisher-Grinberg S; Einat H
J Pharmacol Toxicol Methods; 2009; 59(3):141-5. PubMed ID: 19341808
[TBL] [Abstract][Full Text] [Related]
6. Proposing the sweet solution preference test as a screening assay for anti-manic effects of mood stabilizers.
Kara N; Flaisher-Grinberg S; Einat H
J Neurosci Methods; 2020 Dec; 346():108920. PubMed ID: 32937157
[TBL] [Abstract][Full Text] [Related]
7. Partial effects of the protein kinase C inhibitor chelerythrine in a battery of tests for manic-like behavior in black Swiss mice.
Einat H
Pharmacol Rep; 2014 Aug; 66(4):722-5. PubMed ID: 24948079
[TBL] [Abstract][Full Text] [Related]
8. Introducing Female Black Swiss Mice: Minimal Effects of Sex in a Strain-Specific Battery of Tests for Mania-Like Behavior and Response to Lithium.
Ene HM; Kara NZ; Einat H
Pharmacology; 2015; 95(5-6):224-8. PubMed ID: 25924800
[TBL] [Abstract][Full Text] [Related]
9. Behavioral differences in black Swiss mice from separate colonies: implications for modeling domains of mania.
Juetten J; Einat H
Behav Pharmacol; 2012 Apr; 23(2):211-4. PubMed ID: 22193594
[TBL] [Abstract][Full Text] [Related]
10. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
11. The effects of the atypical antipsychotic asenapine in a strain-specific battery of tests for mania-like behaviors.
Ene HM; Kara NZ; Einat H
Behav Pharmacol; 2015 Jun; 26(4):331-7. PubMed ID: 25590966
[TBL] [Abstract][Full Text] [Related]
12. Different behaviors and different strains: potential new ways to model bipolar disorder.
Einat H
Neurosci Biobehav Rev; 2007; 31(6):850-7. PubMed ID: 17307253
[TBL] [Abstract][Full Text] [Related]
13. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
Soares-Weiser K; Bravo Vergel Y; Beynon S; Dunn G; Barbieri M; Duffy S; Geddes J; Gilbody S; Palmer S; Woolacott N
Health Technol Assess; 2007 Oct; 11(39):iii-iv, ix-206. PubMed ID: 17903393
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a battery of simple models for facets of bipolar disorder: a practical approach to achieve increased validity, better screening and possible insights into endophenotypes of disease.
Einat H
Behav Genet; 2007 Jan; 37(1):244-55. PubMed ID: 16865528
[TBL] [Abstract][Full Text] [Related]
15. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
Munch G; Godart N
Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
[TBL] [Abstract][Full Text] [Related]
16. Indoleamine-2,3-dioxygenase-1 is a molecular target for the protective activity of mood stabilizers against mania-like behavior induced by d-amphetamine.
Tran HQ; Shin EJ; Saito K; Tran TV; Phan DH; Sharma N; Kim DW; Choi SY; Jeong JH; Jang CG; Cheong JH; Nabeshima T; Kim HC
Food Chem Toxicol; 2020 Feb; 136():110986. PubMed ID: 31760073
[TBL] [Abstract][Full Text] [Related]
17. Trehalose induced antidepressant-like effects and autophagy enhancement in mice.
Kara NZ; Toker L; Agam G; Anderson GW; Belmaker RH; Einat H
Psychopharmacology (Berl); 2013 Sep; 229(2):367-75. PubMed ID: 23644913
[TBL] [Abstract][Full Text] [Related]
18. Questioning the predictive validity of the amphetamine-induced hyperactivity model for screening mood stabilizing drugs.
Lan A; Einat H
Behav Brain Res; 2019 Apr; 362():109-113. PubMed ID: 30630015
[TBL] [Abstract][Full Text] [Related]
19. Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK3) inhibitors in a strain-specific model of acute mania.
Kalinichev M; Dawson LA
Int J Neuropsychopharmacol; 2011 Sep; 14(8):1051-67. PubMed ID: 21208504
[TBL] [Abstract][Full Text] [Related]
20. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.
Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R
Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
